Cangene to acquire Chesapeake Biological

Cangene (TSE:CNJ) will acquire CBLI for $4.60 per CBLI share or about $42 million in cash. CBLI develops pharmaceuticals and medical devices and provides manufacturing services; CNJ develops, manufact...